期刊文献+

线粒体融合蛋白-2基因增强人乳腺癌T47D细胞对小白菊内酯的敏感性 被引量:3

Mitofusin-2 gene enhances sensitivity of human breast cancer T47D cells to parthenolide
下载PDF
导出
摘要 目的:探讨线粒体融合蛋白-2(mitofusin-2,Mfn-2)基因表达对人乳腺癌T47D细胞对小白菊内酯敏感性的影响。方法:Real-time PCR检测不同乳腺癌细胞系(T47D、MDA-MB-231、MCF-7、MDA-MB-435及HCC38)中Mfn-2 mRNA的表达。LipofectamineTM2000体外转染pEGFP和pEGFP-Mfn-2质粒至人乳腺癌T47D细胞,real-time PCR和Western blotting检测T47D细胞中Mfn-2 mRNA和蛋白的表达,MTT法检测T47D细胞的增殖,流式细胞术检测T47D细胞凋亡率及线粒体膜电位。结果:与正常乳腺细胞相比,Mfn-2 mRNA在乳腺癌HCC38细胞系中高表达,在T47D等其他细胞系中均低表达。pEGFP-Mfn-2转染48 h后,T47D细胞中Mfn-2 mRNA和蛋白的表达均明显上调。与pEGFP转染组相比,pEGFP-Mfn-2转染组T47D细胞在小白菊内酯(0.05 mol/L)作用下的存活率明显降低[(47.93±2.21)%vs(56.93±2.05)%,P<0.05]。流式细胞术检测结果显示:50 mmol/L小白菊内酯作用下,pEGFP-Mfn-2转染组与pEGFP转染组相比,T47D细胞凋亡率升高[(71.2±2.1)%vs(38.8±2.6)%,P<0.05],而线粒体膜电位明显降低[(1.6±0.1)%vs(5.0±0.5)%,P<0.05]。结论:pEGFP-Mfn-2转染可增强T47D细胞对小白菊内酯的敏感性。 Objective:To investigate the effect of mitofusin-2 ( Mfn-2 ) gene expression on sensitivity of human breast cancer T47D cells to parthenolide. Methods: The expressions of Mfn-2 mRNA in various breast cancer cell lines (T47D, MDA-MB-231, MCF-7, MDA-MB-435 and HCC38) were detected by real-time PCR. Plasmids pEGFP and pEGFP-Mfn-2 were transfected into human breast cancer T47D cells by LipofectamineTM 2000 in vitro. The expression levels of Mfn-2 mRNA and protein in T47D cells were detected by real-time PCR and Western blotting. MTT assay was used to detect the proliferation of T47D cells. The cell apoptotic rate and mitochondrial membrane potential of T47D cells were measured by flow cytometry. Results: Compared with that in normal breast cells, Mfn-2 mRNA was highly expressed in breast cancer HCC38 cell line, and lowly expressed in the other cell lines, such as T47D etc. After pEGFP-Mfn-2 transfection for 48 h, the expression levels of Mfn-2 mRNA and rotein were significantly up-regulated in T47D cells. Compared with the pEGFP transfection group, the pEGFP-Mfn-2 transfection group showed a significant decrease in surivival rate of T47D cells under the treatment of parthenolide (50 mmol/L) (/[47.93±2.21/]% vs /[56.93±2.05/]%, P〈0.05). Flow cytometry results showed that the apoptotic rate of T47D cells under the treatment of 0.05 mol/L parthenolide was significantly increased in pEGFP-Mfn-2 transfection group compared with that in pEGFP ransfection group (/[71.2±2.1/] % vs /[38.8±2.6/] %, P〈005). However, the mitochondrial membrane potential was significanly decreased in the pEGFP-Mfn-2 transfection group (/[1.6±0.1/] % vs /[5.0±0.5/] %, P〈0.05). Conclusion: pEGFP-Mfn-2 transfection can enhance the sensitivity of T47D cells to parthenolide.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2013年第1期37-42,共6页 Chinese Journal of Cancer Biotherapy
基金 天津市自然科学基金资助项目(No.10JCYBJC11500)~~
关键词 乳腺癌 T47D细胞 线粒体融合蛋白-2 小白菊内酯 敏感性 breast cancer T47D cell mitofusin-2 parthenolide sensitivity
  • 相关文献

参考文献22

  • 1Liu JW,Cai MX,Xin Y. Parthenolide induces proliferation inhibition and apoptosis of pancreatic cancer cells in vitro[J].Journal of Experimental & Clinical Cancer Research,2010,(01):108-114.
  • 2Park JH,Liu L,Kim IH. Identification of the genes involved in enhanced fenretinide-induced apoptosis by parthenolide in human hepatoma cells[J].Cancer Research,2005,(07):2804-2814.
  • 3Shanmugam R,Kusumanchi P,Cheng L. A water-soluble parthenolide analogue suppresses in vivo prostate cancer growth by targeting[J].Prostate,2010,(10):1074-1086.
  • 4Sohma I,Fujiwara Y,Sugita Y. Parthenolide,an NF-κB inhibitor,suppresses tumor growth and enhances response to chemotherapy in gastric cancer[J].Cancer Genomics Proteomics,2010,(01):39-47.
  • 5Parada-turska J,Paduch R,Majdan M. Antiproliferative activity of parthenolide against three human cancer cell lines and human umbilical vein endothelial cells[J].PHARMACOLOGICAL REPORTS,2007,(02):233-237.
  • 6Chen KH,Guo X,Ma D. Dysregulation of HSG triggers vascular proliferative disorders[J].Nature Cell Biology,2004,(09):872-883.
  • 7Huang P,Yu T,Yoon Y. Mitochondrial clustering induced by overexpression of the mitochondrial fusion protein Mfn2 causes mitochondrial dysfunction and cell death[J].European Journal of Cell Biology,2007,(06):289-302.doi:10.1016/j.ejcb.2007.04.002.
  • 8Zorzano A,Liesa M,Sebastian D. Mitochondrial fusion proteins:Dual regulators of morphology and metabolism[J].Seminars in Cell and Developmental Biology,2004,(06):566-574.
  • 9Zhang S,Ong CN,Shen HM. Involvement of proapoptotic Bcl-2 family members in parthenolide-induced mitochondrial dysfunction and apoptosis[J].Cancer Letters,2004,(02):175-188.
  • 10Hayashi S,Koshiba K,Hatashita M. Thermosensitization and induction of apoptosis or cell-cycle arrest via the MAPK cascade by parthenolide,an NF-κB inhibitor,in human prostate cancer androgen-independent cell lines[J].International Journal of Molecular Medicine,2010,(06):1033-1042.

二级参考文献20

  • 1王钧,吴开春,张德新,幺立萍,樊代明.人血管生成素-1基因转染对胃癌细胞体内致瘤力及血管生成的影响[J].中华肿瘤杂志,2005,27(2):77-80. 被引量:6
  • 2陈余清,李伟,周继红,李殿明,夏雪梅,黄礼年,李柏青.survivin抗肺癌细胞凋亡的分子机制[J].中华肿瘤杂志,2006,28(6):413-417. 被引量:21
  • 3Santel A,Fuller M T.Control of mitochondrial morphology by a human mitofusin[J].J Cell Sci,2001,114(5):867-874.
  • 4Rojo M,Legros F,Chateau D,et al.Membrane topology and mitochondrial targeting of mitofusins,ubiquitous mammalian homologs of the transmembrane GTPase Fzo[J].J Cell Sci,2002,115(8):1663-1674.
  • 5Karbowski M,Lee Y J,Gaume B,et al.Spatial and temporal association of Bax with mitochondrial fission sites,Drp1,and Mfn2 during apoptosis[J].J Cell Biol,2002,159(6):931-938.
  • 6Chen H,Detmer S A,Ewald A J,et al.Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development[J].J Cell Biol,2003,160(2):189-200.
  • 7Santel A.Get the balance right:mitofusins roles in health and disease[J].Biochim Biophys Acta,2006,1763 (5 -6):490-499.
  • 8Chen K,Guo X,Ma D,et al.Dysregulation of HSG triggers vascular proliferative disorders[J].Nat Cell Biol,2004,6 (9):872-883.
  • 9Hofmann W K,Takeuchi S,Xie D,et al.Frequent loss of heterozygosity in the region of D1S450 at 1p36.2 in myelidysplastic syndromes[J].Leuk Res,2001,25(10):855-858.
  • 10Hogarty M D,Maris J M,White P S,et al.Analysis of genomic imprinting at 1p35-36 in neuroblastoma[J].Med Pediatr Oncol,2001,36(1):52-55.

共引文献14

同被引文献27

  • 1王萍,毋丽娜,蒋春笋,李志新,张颖妹,陈光慧,邱晓彦.人增殖抑制基因(HSG)对肿瘤细胞系化疗敏感性的作用[J].北京大学学报(医学版),2005,37(2):117-120. 被引量:15
  • 2夏耘,吴亚群,张林,李小兰,袁惠玲,何小军,陶德定,龚建平,裘法祖.线粒体融合素基因-2对人乳腺癌MCF-7细胞株增殖与化疗敏感性的影响[J].癌症,2007,26(8):815-819. 被引量:12
  • 3夏耘,吴亚群,郑启昌,张玮,龚建平,裘法祖.线粒体融合素基因-2对乳腺癌细胞凋亡的影响[J].中华肿瘤杂志,2007,29(9):653-656. 被引量:6
  • 4Whicha MS, Liu S, Dontu G. Cancer stem cells: An old idea-a paradigm shift [J]. Cancer Res, 2006, 66(4) : 1883-1890.
  • 5Linheng Li, Neaves WB. Normal stem cells and cancer stem cells The niche matters [J]. Cancer Res, 2006, 66(9) : 4553-4557.
  • 6Walker MR, Patel KK, Stappenbeck TS. The stem cell niche [J]. J Pathol, 2009, 217(2) : 169-180.
  • 7Yi SY, Hao YB, Nan K J, et al. Cancer stem cells niche : A target for novel cancer therapeutics [ J]. Cancer Treat Rev, 2013, 39 (3) : 290-296.
  • 8Kawasaki BT, Hurt EM, Kalathur M, et al. Effects of the sesquit- erpene lactone parthenolide on prostate tumor-initiating ceils: An integrated molecular profiling approach [ J ]. Prostate, 2009, 69 ( 8 ) : 827-837.
  • 9Witek-Zawada B, Koj A. Regulation of expression of stromyelysin-1 by proinflammatory cytokines in mouse brain astrocytes [ J ]. J Physiol Pharmacol, 2003, 54(4) : 489-496.
  • 10Sohmu I, Sugitu Y, Fujiwara Y, et al. Parthenolide, an NF-κB inhibitor supressers tumor growth and enhances reponse to chemotherapy in gastric cancer [ J ]. Cancer Gemomies Protecmics, 2010, $(1) : 39-47.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部